Our proprietary GENIISYS™ platform consists of a large and fast-growing bio- and data-repository of deeply-phenotyped consented research participants. The diverse dataset has the potential to power understanding across multiple disease areas of interest including cancers, neurodegenerative diseases, sickle cell, autoimmune and rare diseases, and infectious diseases.
As a pioneer in progressing insights derived from the African genome, we combine our in-house data analytics and bioinformatics expertise to translate genomics data into actionable insights that fuel global drug target discovery.
We are committed to infrastructure-building in Africa and building ecosystem partnerships that advance the continent's precision medicine capabilities for the long-term; thereby enabling better treatment outcomes within Africa, and further enabling the continuous inclusion of the African genome in global research.
To keep up to date with events, services and initiatives, subscribe to our newsletter today.